Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 22 Sept 2006 |
| Genmab, articles of association on September 19, 2006 | 22 Sept 2006 |
| Genmab, Grant of Warrants in Genmab A/S | 20 Sept 2006 |
| Genmab, Capital Increase in Genmab as a Result of Employee Warrant Exercise | 20 Sept 2006 |
| Genmab, Report Pursuant to Section 28a of the Danish Securities Trading Act | 20 Sept 2006 |